28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report .
90th Health Research Report 26 SEP 2010 – Reconstruction engineeringevil.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from engineeringevil.com Daily Mail and Mail on Sunday newspapers.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has secured the aid of Quest Pharmaceutical Services to provide regulatory advice and manage clinical trials.